GlassScriptPhysician profile
Kintin Ng
NPI 1316408065
$3,932.93
in general payments reported to CMS, 2019-2025
20 companies · $515 in 2025
The $515 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $632 · 2023: $1,332 · 2024: $1,453 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,221 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,221.23 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,272.31 | 2022-2025 | Breztri, Tezspire, Airsupra |
| Insmed, INC. | $332.07 | 2022-2024 | Arikayce |
| Glaxosmithkline, LLC. | $241.00 | 2023-2025 | Nucala, Trelegy Ellipta |
| Abiomed | $226.60 | 2024 | Impella |
| Actelion Pharmaceuticals US, INC. | $186.35 | 2023-2024 | Opsumit, Uptravi |
| Stryker Corporation | $147.35 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.00 | 2023-2025 | Ofev |
| Mallinckrodt Hospital Products INC. | $146.21 | 2024 | Terlivaz |
| Genentech, INC. | $145.14 | 2023 | |
| Grifols USA, LLC | $136.73 | 2024-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $134.39 | 2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Mylan Specialty L.P. | $124.95 | 2023 | Yupelri |
| Inspire Medical Systems, INC. | $117.84 | 2023 | Inspire |
| Harmony Biosciences LLC | $111.00 | 2023-2024 | Wakix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $109.20 | 2025 | |
| Melinta Therapeutics, LLC | $102.09 | 2024 | Vabomere |
| Amgen INC. | $50.91 | 2022-2023 | Tezspire |
| Jazz Pharmaceuticals INC. | $50.72 | 2022-2023 | |
| Pharming Healthcare, INC. | $26.07 | 2023 | Ruconest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kintin Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.